startups
Most Read
In another sign of RNA’s growing popularity, the cancer startup Replicate is relaunching
Flagship, Orbimed, ARCH, Alta top list of high-performing biotech venture capital firms
Startup Spotlight: Vigil Neuroscience hopes to eventually target the rare disease ALSP
Startup Spotlight: Encoded eyes a gene therapy for Dravet syndrome
How much is a startup worth? For biotech companies, the answer is rarely public
5 top blunders life science startups make on the road to clinical trials
Once a small player among biotech VCs, Mubadala Capital Ventures is punching above its weight
All Coverage
advertisement
